title: Cytokines as biomarkers of nanoparticle immunotoxicity.
abstract: Nanoscale objects, whether of biologic origin or synthetically created, are being developed into devices for a variety of bionanotechnology diagnostic and pharmaceutical applications. However, the potential immunotoxicity of these nanomaterials and mechanisms by which they may induce adverse reactions have not received sufficient attention. Nanomaterials, depending on their characteristics and compositions, can interact with the immune system in several ways and either enhance or suppress immune system function. Cytokines perform pleiotropic functions to mediate and regulate the immune response and are generally recognized as biomarkers of immunotoxicity. While the specificity and validity of certain cytokines as markers of adverse immune response has been established for chemicals, small and macromolecular drugs, research on their applicability for predicting and monitoring the immunotoxicity of engineered nanomaterials is still ongoing. The goal of this review is to provide guidelines as to important cytokines that can be utilized for evaluating the immunotoxicity of nanomaterials and to highlight the role of those cytokines in mediating adverse reactions, which is of particular importance for the clinical development of nanopharmaceuticals and other nanotechnology-based products. Importantly, the rational design of nanomaterials of low immunotoxicity will be discussed, focusing on synthetic nanodevices, with emphasis on both the nanoparticle-forming materials and the embedded cargoes.
authors.affiliation: Department of Chemistry, and Laboratory for Synthetic-Biologic Interactions, Texas A&M University, P.O. Box 30012, 3255 TAMU, College Station, Texas 77842-3012, USA. mahmoud.elsabahy@chem.tamu.edu
authors.forename: Mahmoud
authors.initials: M
authors.lastname: Elsabahy
authors.forename: Karen L
authors.initials: KL
authors.lastname: Wooley
mesh_terms: D015415:Biomarkers / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism*; D004337:Drug Carriers / Q000737:chemistry; D006801:Humans; D007107:Immune System / Q000187:drug effects / Q000378:metabolism; D056747:Immunomodulation; D050997:Nanomedicine; D049329:Nanostructures / Q000737:chemistry* / Q000633:toxicity; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000378:metabolism
chemical_list: D015415:Biomarkers; D016207:Cytokines; D004337:Drug Carriers
references.citation: Oncol Rep. 2011 Jul;26(1):201-8
references.pmid: 21491089
references.citation: Nat Rev Immunol. 2008 Jan;8(1):59-73
references.pmid: 18097448
references.citation: Biomacromolecules. 2007 Oct;8(10):3126-34
references.pmid: 17880180
references.citation: Hum Gene Ther. 1997 Apr 10;8(6):689-707
references.pmid: 9113509
references.citation: J Immunol. 2005 Jul 1;175(1):5-14
references.pmid: 15972624
references.citation: J Immunol. 2010 Mar 1;184(5):2729-35
references.pmid: 20107184
references.citation: J Hazard Mater. 2011 Nov 15;195:365-70
references.pmid: 21907489
references.citation: Analyst. 2009 Mar;134(3):425-39
references.pmid: 19238274
references.citation: N Engl J Med. 2006 Sep 7;355(10):1018-28
references.pmid: 16908486
references.citation: Methods Mol Biol. 2011;728:195-206
references.pmid: 21468949
references.citation: Occup Environ Med. 2007 Sep;64(9):609-15
references.pmid: 17409182
references.citation: Vaccine. 2009 Feb 18;27(8):1230-41
references.pmid: 19114079
references.citation: Trends Mol Med. 2007 Nov;13(11):460-9
references.pmid: 18029230
references.citation: Eur J Immunol. 1991 Sep;21(9):2177-84
references.pmid: 1889462
references.citation: Part Fibre Toxicol. 2007 Feb 27;4:2
references.pmid: 17326846
references.citation: Cytometry B Clin Cytom. 2009 May;76(3):159-68
references.pmid: 18823005
references.citation: Acc Chem Res. 2008 Jan;41(1):60-8
references.pmid: 17867649
references.citation: Nat Rev Genet. 2008 Oct;9(10):776-88
references.pmid: 18781156
references.citation: Toxicol Appl Pharmacol. 2007 Jul 15;222(2):141-51
references.pmid: 17599375
references.citation: Clin Pharmacol Ther. 2008 Nov;84(5):628-32
references.pmid: 18800034
references.citation: J Biomed Mater Res A. 2011 Dec 15;99(4):607-17
references.pmid: 21953904
references.citation: Curr Eye Res. 2005 Apr;30(4):299-307
references.pmid: 16020260
references.citation: Toxicol Appl Pharmacol. 2008 Apr 15;228(2):200-11
references.pmid: 18261754
references.citation: Hum Gene Ther. 2001 May 1;12(7):751-61
references.pmid: 11339892
references.citation: J Control Release. 2011 Nov 7;155(3):344-57
references.pmid: 21723891
references.citation: Toxicol Lett. 2008 Jan 30;176(2):131-7
references.pmid: 18079072
references.citation: Toxicol Sci. 2006 May;91(1):227-36
references.pmid: 16495353
references.citation: Nat Biotechnol. 2005 Apr;23(4):457-62
references.pmid: 15778705
references.citation: Angew Chem Int Ed Engl. 2009;48(23):4174-9
references.pmid: 19408274
references.citation: J Clin Invest. 2009 Mar;119(3):661-73
references.pmid: 19229107
references.citation: Annu Rev Immunol. 2003;21:335-76
references.pmid: 12524386
references.citation: Adv Drug Deliv Rev. 2008 May 22;60(8):886-98
references.pmid: 18374448
references.citation: Acc Chem Res. 2011 Oct 18;44(10):1123-34
references.pmid: 21692448
references.citation: Anticancer Drugs. 2005 Mar;16(3):243-54
references.pmid: 15711176
references.citation: Coron Artery Dis. 1997 Mar-Apr;8(3-4):143-7
references.pmid: 9237023
references.citation: Biomaterials. 2012 Nov;33(33):8557-68
references.pmid: 22901966
references.citation: Part Fibre Toxicol. 2009 Dec 31;6:35
references.pmid: 20043844
references.citation: Nat Nanotechnol. 2008 Jul;3(7):423-8
references.pmid: 18654567
references.citation: J Toxicol Environ Health A. 2010;73(5):396-409
references.pmid: 20155581
references.citation: Pharmacol Ther. 2006 Dec;112(3):630-48
references.pmid: 16815554
references.citation: Nanomedicine. 2011 Jun;7(3):315-23
references.pmid: 21050894
references.citation: Blood. 2011 Dec 22;118(26):6836-44
references.pmid: 21967977
references.citation: Clin J Oncol Nurs. 2007 Feb;11(1 Suppl):37-42
references.pmid: 17471824
references.citation: J Biomed Nanotechnol. 2011 Feb;7(1):193-4
references.pmid: 21485866
references.citation: Antimicrob Agents Chemother. 1999 Sep;43(9):2273-7
references.pmid: 10471578
references.citation: Nat Nanotechnol. 2007 Aug;2(8):469-78
references.pmid: 18654343
references.citation: Toxicol Appl Pharmacol. 2012 Jan 15;258(2):151-65
references.pmid: 22178382
references.citation: J Immunol. 2007 Sep 1;179(5):3325-31
references.pmid: 17709549
references.citation: Adv Drug Deliv Rev. 2009 Jun 21;61(6):428-37
references.pmid: 19376175
references.citation: J Drug Target. 2011 Dec;19(10):925-32
references.pmid: 22023509
references.citation: Cancer Immunol Immunother. 2000 Jul;49(4-5):181-5
references.pmid: 10941900
references.citation: Science. 2006 Feb 3;311(5761):622-7
references.pmid: 16456071
references.citation: Inhal Toxicol. 2009 Jul;21 Suppl 1:115-22
references.pmid: 19558243
references.citation: Biochem Biophys Res Commun. 1999 Sep 24;263(2):398-404
references.pmid: 10491305
references.citation: Am J Physiol Lung Cell Mol Physiol. 2005 Nov;289(5):L698-708
references.pmid: 15951334
references.citation: Biomacromolecules. 2008 Jul;9(7):1997-2006
references.pmid: 18510359
references.citation: Chem Soc Rev. 2012 Apr 7;41(7):2545-61
references.pmid: 22334259
references.citation: Nanomedicine. 2012 Aug;8(6):987-95
references.pmid: 22100755
references.citation: Occup Environ Med. 2004 May;61(5):442-7
references.pmid: 15090666
references.citation: BMC Immunol. 2009 Jul 24;10:40
references.pmid: 19630977
references.citation: Nano Lett. 2006 Aug;6(8):1682-6
references.pmid: 16895356
references.citation: Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1410-5
references.pmid: 18230737
references.citation: Nat Biotechnol. 2005 Aug;23(8):1002-7
references.pmid: 16041363
references.citation: Small. 2013 May 27;9(9-10):1595-607
references.pmid: 23180683
references.citation: Eur J Immunol. 2001 Aug;31(8):2448-57
references.pmid: 11500829
references.citation: Nanomedicine. 2006 Sep;2(3):158-68
references.pmid: 17292138
references.citation: ScientificWorldJournal. 2011 Feb 14;11:382-90
references.pmid: 21336454
references.citation: Biomaterials. 2009 Aug;30(23-24):3934-45
references.pmid: 19403166
references.citation: Mol Pharm. 2010 Jun 7;7(3):727-37
references.pmid: 20429563
references.citation: Vaccine. 1999 Aug 20;18(1-2):140-52
references.pmid: 10501244
references.citation: J Endocrinol. 2003 Nov;179(2):139-44
references.pmid: 14596665
references.citation: Vaccine. 1988 Jun;6(3):253-6
references.pmid: 3420974
references.citation: J Invest Dermatol. 2007 Jan;127(1):143-53
references.pmid: 16902417
references.citation: Eur J Pharm Biopharm. 2009 Jun;72(2):370-7
references.pmid: 18775492
references.citation: Cell Mol Life Sci. 2010 May;67(10):1643-51
references.pmid: 20229126
references.citation: J Polym Sci A Polym Chem. 2012 May 15;50(10):1869-1880
references.pmid: 25574072
references.citation: Mol Ther. 2008 Jan;16(1):8-15
references.pmid: 17955026
references.citation: Basic Clin Pharmacol Toxicol. 2010 Feb;106(2):114-7
references.pmid: 19874288
references.citation: Immunol Rev. 2011 Jul;242(1):258-71
references.pmid: 21682751
references.citation: J Control Release. 2005 Dec 5;109(1-3):120-6
references.pmid: 16297482
references.citation: Mol Pharm. 2011 Apr 4;8(2):405-15
references.pmid: 21189035
references.citation: Nat Immunol. 2004 Oct;5(10):987-95
references.pmid: 15454922
references.citation: Nat Nanotechnol. 2011 Jan;6(1):39-44
references.pmid: 21170037
references.citation: J Appl Physiol (1985). 2010 May;108(5):1357-64
references.pmid: 20224000
references.citation: Lancet. 1999 Mar 20;353(9157):947-54
references.pmid: 10459902
references.citation: Anticancer Res. 2010 Oct;30(10):4075-9
references.pmid: 21036722
references.citation: Environ Health Perspect. 2006 Sep;114(9):1325-30
references.pmid: 16966083
references.citation: J Clin Invest. 2009 Aug;119(8):2231-44
references.pmid: 19620771
references.citation: Biomacromolecules. 2008 Apr;9(4):1329-39
references.pmid: 18338840
references.citation: Nat Biotechnol. 2007 Oct;25(10):1159-64
references.pmid: 17873867
references.citation: Biomaterials. 2010 Mar;31(7):1805-13
references.pmid: 19878990
references.citation: J Immunol. 1985 Dec;135(6):3972-7
references.pmid: 2999236
references.citation: Altern Med Rev. 2003 Aug;8(3):223-46
references.pmid: 12946237
references.citation: Vaccine. 2008 Sep 15;26(39):5046-57
references.pmid: 18680779
references.citation: Nat Nanotechnol. 2009 Jul;4(7):411-4
references.pmid: 19581891
references.citation: J Control Release. 2005 Dec 5;109(1-3):169-88
references.pmid: 16289422
references.citation: Nat Rev Drug Discov. 2011 Jul 01;10(7):521-35
references.pmid: 21720407
references.citation: Nature. 2006 May 4;441(7089):111-4
references.pmid: 16565705
references.citation: Biomaterials. 2012 Jun;33(18):4762-72
references.pmid: 22465338
references.citation: J Control Release. 2010 Nov 1;147(3):342-9
references.pmid: 20727926
references.citation: Methods. 2006 Apr;38(4):317-23
references.pmid: 16481199
references.citation: Nat Biotechnol. 2010 Feb;28(2):172-6
references.pmid: 20081866
references.citation: Proc Am Thorac Soc. 2009 Aug 15;6(5):450-7
references.pmid: 19687218
references.citation: ACS Nano. 2011 Jun 28;5(6):4422-33
references.pmid: 21557611
references.citation: Hum Gene Ther. 1999 Jan 20;10(2):223-34
references.pmid: 10022547
references.citation: Mol Pharm. 2010 Aug 2;7(4):1098-107
references.pmid: 20476756
references.citation: Environ Health Perspect. 2007 Feb;115(2):187-94
references.pmid: 17384763
references.citation: Adv Exp Med Biol. 2005;560:11-8
references.pmid: 15932016
references.citation: Nat Med. 2002 Jun;8(6):567-73
references.pmid: 12042806
references.citation: J Gene Med. 2009 Aug;11(8):708-17
references.pmid: 19462411
references.citation: Nat Nanotechnol. 2011 Nov 06;6(12):824-33
references.pmid: 22056725
references.citation: J Autoimmun. 2010 May;34(3):J234-46
references.pmid: 19995678
references.citation: Hum Gene Ther. 2008 Feb;19(2):111-24
references.pmid: 18230025
references.citation: Curr Opin Rheumatol. 2007 May;19(3):302-7
references.pmid: 17414960
references.citation: J Immunol. 2010 Jun 15;184(12):7100-7
references.pmid: 20483769
references.citation: Neuroscience. 2010 Jan 20;165(2):445-54
references.pmid: 19892005
references.citation: Cancer Gene Ther. 2007 Aug;14(8):717-23
references.pmid: 17557109
references.citation: Crit Rev Toxicol. 2009;39(7):613-26
references.pmid: 19650720
references.citation: Clin Cancer Res. 2007 Feb 15;13(4):1076-82
references.pmid: 17317814
references.citation: J Toxicol Environ Health A. 2010;73(11):748-56
references.pmid: 20391117
references.citation: J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):2796-803
references.pmid: 17048485
references.citation: Mol Cells. 2007 Oct 31;24(2):247-54
references.pmid: 17978578
references.citation: Toxicol Lett. 2003 Dec 15;146(1):65-73
references.pmid: 14615068
references.citation: ACS Nano. 2009 Sep 22;3(9):2523-32
references.pmid: 19769402
references.citation: Chem Soc Rev. 2011 Jul;40(7):3391-404
references.pmid: 21629885
references.citation: Acc Chem Res. 2011 Oct 18;44(10):969-78
references.pmid: 21675721
references.citation: Adv Drug Deliv Rev. 2007 Mar 30;59(2-3):153-63
references.pmid: 17459518
references.citation: J Pharm Biomed Anal. 2007 Aug 15;44(4):914-23
references.pmid: 17590559
references.citation: Annu Rev Immunol. 1999;17:593-623
references.pmid: 10358769
references.citation: Nature. 2010 Apr 15;464(7291):1067-70
references.pmid: 20305636
references.citation: Vaccine. 2012 Jan 5;30(2):307-16
references.pmid: 22079079
references.citation: Nat Rev Drug Discov. 2010 Aug;9(8):615-27
references.pmid: 20616808
references.citation: Mol Pharm. 2007 Jan-Feb;4(1):73-84
references.pmid: 17274665
references.citation: PLoS Negl Trop Dis. 2010 Nov 23;4(11):e892
references.pmid: 21124882
references.citation: Biomaterials. 2012 Oct;33(28):6858-67
references.pmid: 22770526
references.citation: Mol Pharm. 2005 Jan-Feb;2(1):22-8
references.pmid: 15804174
references.citation: Mol Ther. 2008 May;16(5):942-6
references.pmid: 18388916
references.citation: Arch Toxicol. 2012 Aug;86(8):1297-307
references.pmid: 22418595
references.citation: Mol Pharm. 2008 Jul-Aug;5(4):487-95
references.pmid: 18510338
references.citation: Nat Biotechnol. 2007 Oct;25(10):1149-57
references.pmid: 17873866
references.citation: Toxicol Lett. 2011 Jun 10;203(2):97-105
references.pmid: 21392560
references.citation: Mol Ther. 2011 Mar;19(3):567-75
references.pmid: 21179008
references.citation: Vaccine. 2001 Feb 28;19(15-16):1940-50
references.pmid: 11228364
references.citation: J Immunol. 1998 May 1;160(9):4580-6
references.pmid: 9574565
references.citation: Eur J Pharm Sci. 2009 Nov 5;38(4):283-90
references.pmid: 19733657
references.citation: Hum Gene Ther. 1999 Sep 1;10(13):2153-61
references.pmid: 10498247
references.citation: Br J Haematol. 2011 May;153(3):341-50
references.pmid: 21418175
references.citation: Toxicology. 2007 Sep 5;238(2-3):99-110
references.pmid: 17614186
references.citation: Nanotoxicology. 2012 Feb;6(1):22-35
references.pmid: 21332300
references.citation: Environ Health Perspect. 2005 Jul;113(7):823-39
references.pmid: 16002369
references.citation: J Immunol. 2004 Jun 1;172(11):6545-9
references.pmid: 15153468
references.citation: Vet Immunol Immunopathol. 2002 Sep 6;88(1-2):1-12
references.pmid: 12088639
references.citation: ACS Nano. 2012 Feb 28;6(2):1667-76
references.pmid: 22296103
references.citation: Adv Drug Deliv Rev. 2012 Aug;64(11):979-92
references.pmid: 21996056
references.citation: Drug Discov Today. 2008 Oct;13(19-20):842-55
references.pmid: 18614389
references.citation: Arthritis Rheum. 2010 Feb;62(2):383-91
references.pmid: 20112361
references.citation: BMC Med. 2010 Dec 13;8:83
references.pmid: 21144040
references.citation: N Engl J Med. 2010 Dec 16;363(25):2434-43
references.pmid: 21158659
references.citation: Nat Biotechnol. 2006 May;24(5):493-6
references.pmid: 16680120
references.citation: Dermatol Online J. 1999 May;5(1):7
references.pmid: 10673450
references.citation: Mol Pharm. 2011 Oct 3;8(5):1877-86
references.pmid: 21882825
references.citation: Nanomedicine (Lond). 2010 Jun;5(4):555-62
references.pmid: 20528451
references.citation: Toxicology. 2009 Mar 29;257(3):161-71
references.pmid: 19150385
references.citation: Methods. 2006 Feb;38(2):96-105
references.pmid: 16442811
references.citation: Endocrinology. 2010 Feb;151(2):458-65
references.pmid: 20016026
references.citation: Cold Spring Harb Perspect Biol. 2009 Dec;1(6):a001651
references.pmid: 20457564
references.citation: Biomaterials. 2012 Mar;33(7):2399-407
references.pmid: 22182752
references.citation: Nat Biotechnol. 2008 May;26(5):549-51
references.pmid: 18438402
references.citation: J Immunol. 2004 Sep 1;173(5):3148-54
references.pmid: 15322175
references.citation: Mol Ther. 2006 Mar;13(3):494-505
references.pmid: 16343994
references.citation: Toxicology. 2009 Jun 16;260(1-3):142-9
references.pmid: 19464580
references.citation: Cell Biochem Biophys. 2013 Nov;67(2):461-76
references.pmid: 22669739
references.citation: J Immunol. 1991 Mar 15;146(6):1750-8
references.pmid: 1826010
references.citation: Vaccine. 2007 Jan 26;25(7):1316-27
references.pmid: 17052812
references.citation: Parasite Immunol. 2011 Jun;33(6):335-48
references.pmid: 21410716
references.citation: J Control Release. 2008 Oct 6;131(1):64-9
references.pmid: 18674578
references.citation: Eur J Immunol. 2008 May;38(5):1404-13
references.pmid: 18389478
references.citation: J Gerontol A Biol Sci Med Sci. 2008 Aug;63(8):879-84
references.pmid: 18772478
references.citation: Nat Rev Immunol. 2011 Sep 23;11(10):693-702
references.pmid: 21941295
references.citation: Immunol Cell Biol. 2010 Aug;88(6):621-3
references.pmid: 20531361
references.citation: Part Fibre Toxicol. 2012 Aug 10;9:32
references.pmid: 22882971
references.citation: Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012 Mar-Apr;4(2):169-83
references.pmid: 22144008
references.citation: Nat Mater. 2011 Jun 19;10(7):545-52
references.pmid: 21685903
references.citation: J Biol Chem. 2011 Jun 17;286(24):21844-52
references.pmid: 21525001
references.citation: Toxicol Lett. 2007 Jan 10;168(1):58-74
references.pmid: 17141434
references.citation: Cell Immunol. 1993 Nov;152(1):200-10
references.pmid: 8242760
references.citation: Am J Respir Cell Mol Biol. 1997 Jul;17(1):3-9
references.pmid: 9224203
references.citation: Adv Drug Deliv Rev. 2009 Jun 21;61(6):438-56
references.pmid: 19383522
references.citation: Int J Nanomedicine. 2011;6:605-10
references.pmid: 21674017
references.citation: Mol Ther. 2010 Jan;18(1):171-80
references.pmid: 19738601
references.citation: Pharm Res. 2007 Jan;24(1):1-16
references.pmid: 17109211
references.citation: J Control Release. 2010 Mar 19;142(3):416-21
references.pmid: 19919845
references.citation: Blood. 2010 Jun 3;115(22):4533-41
references.pmid: 20304804
references.citation: Adv Drug Deliv Rev. 2008 May 22;60(8):876-85
references.pmid: 18423779
references.citation: Genet Vaccines Ther. 2003 Oct 27;1(1):3
references.pmid: 14613519
references.citation: Arch Toxicol. 2011 Dec;85(12):1517-28
references.pmid: 21656222
references.citation: Adv Drug Deliv Rev. 2001 Mar 23;47(1):113-31
references.pmid: 11251249